No abstract available
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Aged
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Combined Modality Therapy
-
Female
-
Fever / etiology
-
Headache / etiology
-
Humans
-
Iodine Radioisotopes / adverse effects
-
Iodine Radioisotopes / therapeutic use
-
Kaplan-Meier Estimate
-
Lymphoma, Follicular / pathology
-
Lymphoma, Follicular / therapy*
-
Male
-
Middle Aged
-
Nausea / etiology
-
Neoplasm Recurrence, Local
-
Radioimmunotherapy / methods
-
Rituximab / adverse effects
-
Rituximab / therapeutic use*
-
Thrombocytopenia / etiology
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
Iodine Radioisotopes
-
Rituximab
-
tositumomab I-131
Associated data
-
ClinicalTrials.gov/NCT00268983